NRX Pharmaceuticals rises on smaller Q1 net loss

NRX Pharmaceuticals

16/05/2023 16:32

** Shares of drug developer NRX Pharmaceuticals Inc  NRXP.O 
up 2.47% at $0.69
    ** Q1 net loss decreased to $11 mln from a net loss of $13.4
mln a year earlier
    ** Co remains on track to report initial data from its
suicidal bipolar depression drug in Q4 of 2023
    ** Ended quarter with $16.5 mln in cash and cash equivalents
    ** NRXP stock down ~40% YTD

 (Reporting by Rupali Chaudhary in Bengaluru)
 ((Rupali.chaudhary@thomsonreuters.com))